Rayzebio Inc (RYZB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 129,159 | 50,566 |
| Marketable Securities | 167,087 | 148,600 |
| TOTAL | $300,037 | $202,427 |
| Non-Current Assets | ||
| PPE Net | 15,084 | 5,586 |
| Other Non-Current Assets | 9,655 | 8,372 |
| TOTAL | $24,739 | $13,958 |
| Total Assets | $324,776 | $216,385 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 2,623 | 1,127 |
| Accrued Expenses | 6,691 | 3,159 |
| TOTAL | $10,458 | $6,135 |
| Non-Current Liabilities | ||
| Other Non-Current Liabilities | 425,612 | 264,824 |
| TOTAL | $425,612 | $264,824 |
| Total Liabilities | $436,070 | $270,959 |
| Shareholders' Equity | ||
| Common Shares | 1 | N/A |
| Retained earnings | -130,116 | -55,106 |
| Other shareholders' equity | -553 | -239 |
| TOTAL | $-111,294 | $-54,574 |
| Total Liabilities And Equity | $324,776 | $216,385 |